Biotech

Page 7 of 18

US-ECONOMY-STOCK MARKET
Health

Why Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It

By
April 6, 2018
Najin (R) and Fatu, the only two remaining female northern white rhinoceroses.
Commentary

Commentary: These Technologies Could Save the Northern White Rhino From Extinction

By Nishan Degnarain and Ryan Phelan
March 20, 2018
The psychiatric unit of a hospital in Haute Savoie, France
Health

The Diseases We Aren’t Curing—And Why

By
February 6, 2018
A logo is seen in front of the entrance at the headquarters of French drugmaker Sanofi in Paris
Health

Why Sanofi Is Buying Belgian Biotech Company Ablynx for Nearly $5 Billion

By
January 29, 2018
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health

Why Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal

By
January 22, 2018
Pipetting droplets of liquid into multiwell dish, high angle view
Finance

U.S. Biotech Firm Celgene to Buy Impact Biomedicines for up to $7 Billion

By
January 8, 2018
482179767
Health

This Startup Wants to Democratize CRISPR Gene Editing Research By Making It Free

By
December 13, 2017
Bustling street of China Town in Bangkok
Health

Why American Entrepreneurs Need to Study China’s Biotech Strategy

By
December 12, 2017
Forbes Under 30 Summit
Health

Why SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm

By
August 9, 2017
US-ECONOMY-STOCK MARKET
Health

Why the Biotech Market Has Come Roaring Back in 2017

By
August 4, 2017
Cystic fibrosis drug campaign
Health

This Biotech Just Gained Billions in Market Value Thanks to Its Cystic Fibrosis Drug Cocktail

By
July 19, 2017
Forbes Under 30 Summit
Health

This 31-Year-Old CEO Is Snapping Up Drug Industry Veterans Left and Right

By
July 10, 2017
House GOP
Health

This GOP Congressman Lost $17 Million on a Biotech Investment Gone Wrong

By
June 27, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Fall
Health

Why Cancer Biotech Clovis Oncology’s Stock Is Soaring

By
June 19, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Rise Amid Stronger Job Gains Boost Optimism On Economy
Health

This Biotech’s Stock Plunged 24% After the FDA Rejected Its Amgen Drug Copycat

By
June 12, 2017

Most Popular